Ventus Therapeutics

Ventus Therapeutics is a clinical-stage biopharmaceutical company focused on small-molecule drug discovery for biologically validated targets historically considered undruggable, across inflammatory, immunological, cardiometabolic, and neurological diseases. Its ReSOLVE platform combines AI/ML, protein science, structural biology, and biophysics to accelerate discovery; the pipeline includes VENT-03 (cGAS inhibitor), VENT-02 (NLRP3 inhibitor), and VENT-04 (caspase-4/5 inhibitor). Headquartered in Waltham, Massachusetts with a site in Saint-Laurent, Quebec, and backed by GV and the SoftBank Vision Fund. The company operates no public developer API surface; this profile is maintained in the API Evangelist network as a company/provider record.

Ventus Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Drug Discovery.

Ventus Therapeutics’ developer surface includes engineering blog and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyPharmaceuticalsDrug DiscoveryTherapeuticsAI/ML

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/ventus-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Ventus Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: ventus-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/ventus-therapeutics.png
name: Ventus Therapeutics
description: Ventus Therapeutics is a clinical-stage biopharmaceutical company focused on small-molecule drug discovery for
  biologically validated targets historically considered undruggable, across inflammatory, immunological, cardiometabolic,
  and neurological diseases. Its ReSOLVE platform combines AI/ML, protein science, structural biology, and biophysics to accelerate
  discovery; the pipeline includes VENT-03 (cGAS inhibitor), VENT-02 (NLRP3 inhibitor), and VENT-04 (caspase-4/5 inhibitor).
  Headquartered in Waltham, Massachusetts with a site in Saint-Laurent, Quebec, and backed by GV and the SoftBank Vision Fund.
  The company operates no public developer API surface; this profile is maintained in the API Evangelist network as a company/provider
  record.
url: https://raw.githubusercontent.com/api-evangelist/ventus-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Therapeutics
- AI/ML
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/ventus-therapeutics-domain-security.yml
- type: Website
  url: https://www.ventustx.com
- type: Blog
  url: https://www.ventustx.com/news/
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1